Re-centering overall survival in oncology trials: Interpreting the FDA draft guidance through a global oncology lens

Matheus de Oliveira Andrade, Kleida Mati, Omar Abdihamid, Dario Trapani, Khalid El Bairi

Open source

DOI
10.1016/j.jcpo.2026.100779
Published
2026-09
Container
Journal of Cancer Policy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jcpo.2026.100779,
  title = {Re-centering overall survival in oncology trials: Interpreting the FDA draft guidance through a global oncology lens},
  author = {Matheus de Oliveira Andrade and Kleida Mati and Omar Abdihamid and Dario Trapani and Khalid El Bairi},
  year = {2026},
  journal = {Journal of Cancer Policy},
  doi = {10.1016/j.jcpo.2026.100779},
  url = {https://doi.org/10.1016/j.jcpo.2026.100779}
}

RIS

TY  - JOUR
TI  - Re-centering overall survival in oncology trials: Interpreting the FDA draft guidance through a global oncology lens
AU  - Matheus de Oliveira Andrade
AU  - Kleida Mati
AU  - Omar Abdihamid
AU  - Dario Trapani
AU  - Khalid El Bairi
PY  - 2026
JO  - Journal of Cancer Policy
DO  - 10.1016/j.jcpo.2026.100779
UR  - https://doi.org/10.1016/j.jcpo.2026.100779
ER  - 

APA

Andrade, M. D. O., Mati, K., Abdihamid, O., Trapani, D., & Bairi, K. E. (2026). Re-centering overall survival in oncology trials: Interpreting the FDA draft guidance through a global oncology lens. Journal of Cancer Policy. https://doi.org/10.1016/j.jcpo.2026.100779

Source records